Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1992-02-19
1994-01-18
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Lymphokine
424 9463, 435 23, 435 681, 435 7021, 4351722, 435184, 43524027, 5303881, 5303882, 5303886, 5303911, 436547, 436548, 930240, A61K 3900, C12P 2100, C12N 1500
Patent
active
052798224
ABSTRACT:
A hybridoma is provided which provides a monoclonal antibody of isotope IgG2a, which recognizes a strip corresponding to a peptidic fragment of 8kD, isolated by controlled proteolysis of the 28kD polypeptide of S. mansoni.
REFERENCES:
Dissous et al., The Journal of Immunology, vol. 129, No. 5, pp. 2232-2234, 1982.
Kohler et al., Nature, vol. 256, pp. 495-497, Aug. 7, 1975.
Balloul Jean-Marc
Capron Andre
Grzych Jean-Marie
Pierce Raymond
Institut National de la Sante et de la Recherche Medicale
Institut Pasteur
Institut Pasteur de Lille
Mohamaed Abdel A.
Wityshyn Michael G.
LandOfFree
Monoclonal antibodies against the 28KD protein of S. mansoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies against the 28KD protein of S. mansoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against the 28KD protein of S. mansoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1134940